# | Drug | Count |
---|---|---|
0 | HYDROXYPROGESTERONE CAPROATE | 3642 |
1 | FOLIC ACID | 824 |
2 | PREDNISONE | 807 |
3 | ZIDOVUDINE | 690 |
4 | PREDNISOLONE | 674 |
5 | METHYLDOPA | 673 |
6 | NIFEDIPINE | 672 |
7 | SERTRALINE HYDROCHLORIDE | 618 |
8 | ADALIMUMAB | 564 |
9 | TACROLIMUS | 516 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | METHYLDOPA | 673 | 0.1842 |
1 | HYDROXYPROGESTERONE CAPROATE | 3642 | 0.1768 |
2 | .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, 5-METHYLTETRAHYDROFOLIC ACID, CALCIUM FORMATE, FERROUS ASPARTO GLYCINATE, CYANOCOBALAMIN, BIOTIN, POTASSIUM IODIDE, MAGNESIUM OXIDE, ZINC OXIDE AND CUPRIC OXIDE | 3 | 0.0857 |
3 | CLOMIPHENE CITRATE | 42 | 0.0743 |
4 | OXYTOCIN | 125 | 0.0615 |
5 | ZIDOVUDINE | 690 | 0.0575 |
6 | NELFINAVIR MESYLATE | 113 | 0.0573 |
7 | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | 9 | 0.0545 |
8 | SODIUM CITRATE | 43 | 0.0524 |
9 | NICARDIPINE HYDROCHLORIDE | 58 | 0.0502 |
# | Drug class | Count |
---|---|---|
0 | Corticosteroid [EPC] | 2246 |
1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1629 |
2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1419 |
3 | Platelet Aggregation Inhibitor [EPC] | 1134 |
4 | Tumor Necrosis Factor Blocker [EPC] | 1025 |
5 | Insulin Analog [EPC] | 942 |
6 | Benzodiazepine [EPC] | 904 |
7 | Vitamin C [EPC] | 850 |
8 | Vitamin B12 [EPC] | 846 |
9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 838 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Oxytocic [EPC] | 125 | 0.0615 |
1 | Adrenal Steroid Synthesis Inhibitor [EPC] | 21 | 0.0423 |
2 | Omega-3 Fatty Acid [EPC] | 1 | 0.0278 |
3 | Protease Inhibitor [EPC] | 742 | 0.0274 |
4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 838 | 0.0190 |
5 | Cytochrome P450 3A Inhibitor [EPC] | 739 | 0.0182 |
6 | Progesterone [EPC] | 234 | 0.0166 |
7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1419 | 0.0134 |
8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 589 | 0.0133 |
9 | Surfactant [EPC] | 12 | 0.0127 |